Since 6 Oct 2026, NMC's Guidelines on Ethical Advertising govern how doctors and hospitals in India promote themselves: no testimonials, no superlatives, no inducements and no AI-generated promotional campaigns. Hospitals are also bound by the Clinical Establishments Act or their state act, ads by the ASCI Code, and patient data by the DPDP Act.
This is a working summary for marketing teams, not legal advice. Every rule below names the instrument it comes from so you can read the source rather than take our word for it, and so you can tell when something here has gone out of date.
Go deeper: Our full guide to the NMC Guidelines 2026.
Who regulates healthcare advertising in India
- NMC Guidelines on Ethical Advertising and Public Communication, Public Notice R-13014/01/2024-Ethics (6 Oct 2026)
- Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations 2002 and the NMC Act 2019
- Clinical Establishments (Registration and Regulation) Act 2010 or the applicable state act, for hospitals
- ASCI Code (self-regulatory advertising standards)
- Consumer Protection Act 2019
- Digital Personal Data Protection Act 2023 and DPDP Rules 2025; IT Act 2000
More than one of these usually applies at once. A campaign can satisfy the advertising regulator and still breach the data-protection one, which is the failure mode that catches most practices: the creative gets reviewed and the tracking does not.
The rules that actually change what you can publish
- Doctors may not request or share patient testimonials for promotion, and patient consent does not make them permissible (NMC Expl. V to 3.2, 6.2).
- No “best”, “No.1”, “painless”, “100% success” or guarantee claims unless objectively verifiable through a disclosed, independent method (8.1(iii), 8.1(ix)).
- No discounts, coupons, cashbacks, referral benefits or free procedures as inducements. Factual fee disclosure is allowed (8.1(x)).
- No celebrity, influencer, patient or employee endorsements. Publishing through an agency or influencer does not shift responsibility (8.1(xi), 4.4).
- Agency fees may not be linked to the procurement or referral of individual patients (8.1(viii)).
- AI-generated promotional campaigns are prohibited, and other AI content must carry a source mark (7.2).
- Every post by a doctor discloses name, qualifications, registration status and SMR/NMR number (Expl. III).
- Hospitals may share factual, verifiable information such as departments, facilities, accreditation (e.g. NABH) and charges, read with their Clinical Establishments Act or state act (8.3, 9.1, 4.3).
At a glance: tactic by tactic
| Tactic | Where it stands | What applies |
|---|---|---|
| Patient testimonials | Not permitted | Doctors may not request or share patient testimonials for promotion, and patient consent does not make them permissible. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), Expl. V to 3.2, 6.2, 8.1(xi). |
| Asking for and showing reviews | Narrow exceptions | Doctors may not request reviews for promotion on social media. Fake, paid, incentivised or manipulated reviews are banned for doctors and hospitals. Patients' own reviews can stay; replies must not reveal patient details. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), Expl. V to 3.2, 8.1(xii), 7.4. |
| Before-and-after images | Narrow exceptions | Not for promotion. Allowed only strictly for scientific or educational purposes, with anonymised patient consent. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), 8.1(v), 6.2. |
| “Best”, “No.1” and guarantee claims | Not permitted | No “best”, “No.1”, “top”, “leading”, “painless”, “100% success” or guarantee claims unless objectively verifiable through a disclosed, independent method. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), 8.1(iii), 8.1(ix). |
| Prices, discounts and offers | Narrow exceptions | No discounts, limited-period offers, coupons, cashbacks, referral benefits or free procedures as inducements. Factual fee disclosure is allowed. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), 8.1(x). |
| Influencers and endorsements | Not permitted | No celebrity, influencer, patient or employee endorsements of a doctor's or hospital's services, and no third party doing indirectly what is banned directly. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), 8.1(xi), 4.4. |
| A doctor promoting their own practice | Narrow exceptions | Doctors may not self-promote, solicit patients or engage a third party to market medical services. Public-health education in their own name, factual announcements and hospital doctor directories are allowed. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), 8.1(ii), 5.1, 8.2, 9.1. |
| AI-generated content | Narrow exceptions | AI-generated promotional campaigns are prohibited. Other AI content must carry a source mark, and synthetic patients, voices or doctors are banned. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), 7.2. |
| Patient images and data | Allowed with conditions | Only where law permits, with specific, informed, documented consent. Anonymise by default. The DPDP Act 2023 and its 2025 Rules apply. Source: NMC Public Notice R-13014/01/2024-Ethics (6 Oct 2026), 6.1–6.4, 7.4, 7.6. |
How Branding Pioneers handles it
- Fees are fixed for a defined scope and never linked to patients, appointments, leads or referrals.
- Every public communication is approved in writing by the practice before it goes live, and the approval is logged.
- No testimonials, before/after images, superlatives, inducements or AI-generated people.
- We never buy or manipulate reviews, ratings, followers or search rankings.
- AI-assisted material is disclosed to the practice and source-marked when published.
- Patient data is processed only on documented instructions and in line with the DPDP Act 2023.
Tracking deserves the same scrutiny as copy. Analytics, pixels and remarketing tags routinely collect more than a healthcare provider is permitted to share, and the default installation of most of them is not compliant in India. Audit what your tags send before you audit your ad copy.
Before you run anything
- Can you substantiate every claim in the creative, today, from a document you can produce?
- Do you have written consent for every patient who appears, covering this specific use?
- Has the approval or licence this market requires been granted, and is its number on the creative where required?
- Does your tracking send anything that identifies a patient or their condition?
- Has someone qualified in India reviewed the campaign, not just the marketing team?
If the answer to the last one is no, that is the gap worth closing first. We work inside these rules daily and will tell you when something you want to publish is not worth the exposure, but we are a marketing agency, and a regulated market deserves a qualified reviewer as well.
Not legal advice. A planning summary of published rules, last checked on 11 October 2026. Rules change, so confirm the current text with the regulator or local counsel before relying on it.
